CHMP Issues Positive Opinion To Expand Jardiance®, Synjardy® And Glyxambi® Labels To Include Positive Effects On Cardiovascular And Renal Outcomes

Kurt HarringtonIndustry News, RegulatoryLeave a Comment

Boehringer Ingelheim Logo
Share This:

INGELHEIM, Germany & INDIANAPOLIS–(BUSINESS WIRE)–Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) announced today that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to update … Read More

Araim Pharmaceuticals’ Cibinetide (ARA 290) Regenerates Small Nerve Fibers and Improves Neuropathic Clinical Symptoms in the Orphan Disease of Sarcoidosis

Vault BioventuresClinical Development, Industry NewsLeave a Comment

Araim Pharmaceuticals cibinetide (ara 290)
Share This:

The double blind, randomized, placebo-controlled, two-center study published in Investigative Ophthalmology & Visual Science assessed the safety and efficacy of daily subcutaneous 1, 4, 8 mg cibinetide or placebo for 28 days in 64 patients … Read More